NASDAQ: MPLTMaplight Therapeutics Inc Stock Ownership - Who owns Maplight Therapeutics?
Insider buying vs selling
Have Maplight Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Vishwas Setia | Chief Financial Officer | 2026-01-27 | 33,382 | $17.98 | $600.21kSell |
| Erin Pennock Foff | Chief Medical Officer | 2026-01-27 | 44,616 | $17.98 | $802.20kSell |
| Jonathan Gillis | CAAO and PAO | 2026-01-27 | 22,050 | $17.98 | $396.46kSell |
| Kristopher Hanson | General Counsel | 2026-01-27 | 26,007 | $17.98 | $467.61kSell |
| Anatol Kreitzer | Chief Discovery Officer | 2026-01-27 | 42,099 | $17.98 | $756.94kSell |
| Christopher A. Kroeger | Chief Executive Officer | 2026-01-27 | 204,146 | $17.98 | $3.67MSell |
| James Woodruff Lillie | Chief Scientific Officer | 2026-01-27 | 45,055 | $17.98 | $810.09kSell |
| Holdings A. Novo | 10% Owner | 2025-10-28 | 952,941 | $17.00 | $16.20MBuy |
| Catalyst4 Inc | 10% Owner | 2025-10-28 | 5,441,176 | $17.00 | $92.50MBuy |
MPLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MPLT insiders and whales buy or sell their stock.
MPLT Shareholders
What type of owners hold Maplight Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Catalyst4 Inc | 43.41% | 19,697,464 | $365.98M | Insider |
| Holdings A. Novo | 8.13% | 3,686,622 | $68.50M | Insider |
| Christopher A. Kroeger | 3.81% | 1,727,796 | $32.10M | Insider |
| Robert C. Malenka | 0.95% | 431,343 | $8.01M | Insider |
| Erin Pennock Foff | 0.86% | 390,475 | $7.26M | Insider |
| Vishwas Setia | 0.85% | 387,819 | $7.21M | Insider |
| James Woodruff Lillie | 0.64% | 291,132 | $5.41M | Insider |
| Anatol Kreitzer | 0.56% | 253,908 | $4.72M | Insider |
| Jonathan Gillis | 0.55% | 248,503 | $4.62M | Insider |
| Kristopher Hanson | 0.41% | 183,852 | $3.42M | Insider |
MPLT vs Biotech Stocks
Maplight Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.